Drug Evaluation 2012 Issue 6 Fulvestrant: A New Choice in the Management of Hormone Receptor-positive Metastatic Breast Cancer in Postmenopausal Women

Home | Survey | Payment| Talks & Presentations | Job Opportunities

Journals A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Drug Evaluation
1672-2809
2012 Issue 6

Fulvestrant: A New Choice in the Management of Hormone Receptor-positive Metastatic Breast Cancer in Postmenopausal Women
LIN Xiao-lin;DI Li-jun

..............page:7-9

The Biologische Merkmale and Treatment Strategies of Triple Negative Breast Cancer
ZHU Li;TANG Yi-qing

..............page:13-15

zhong guo kang ai xie hui ru xian ai zhen zhi zhi nan yu gui fan (2011 ban )( xuan deng )

..............page:26-47

Progress in Medical Treatment of Breast Cancer
JIA Zhen;HU Xi-chun

..............page:4-6,9

SABCS: Latest Results from Clinical Rials with Bisphosphonates
LIN Ying

..............page:24-25

The Role of Gemcitabine in the First Line Treatment of Metastatic Breast Cancer
WANG Bi-yun

..............page:16-18

yao pin ping jia ( zhong liu ban ) za zhi bian ji chu ban jie shao

..............page:前插1

Bevacizumab for Breast Cancer
YU Bo

..............page:21-23

The Resistance Mechanism of Aromatase Inhibitors
WANG Shu

..............page:10-12,15

Neoadjuvant Chemotherapy dapted by Interim Response Improves Overall Survival of Primary Breast Cancer Patients
YUAN Peng;XU Bing-he

..............page:19-20,47